Bionano Genomics (BNGO) EBITDA Margin (2017 - 2026)
Bionano Genomics (BNGO) posted EBITDA Margin of 118.09% for Q1 2026, down 10.0% sequentially from 107.36% in Q4 2025, and up 1300.0% YoY from 8.44% in Q1 2025.
Bionano Genomics (BNGO) EBITDA Margin (2017 - 2026) Analysis & Trends
Bionano Genomics has reported EBITDA Margin for 10 years, with the latest figure at 118.09% in Q1 2026.
- Quarterly EBITDA Margin rose 1300.0% year-over-year to 118.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 114.03% (up 17168.0% YoY) and the FY2025 annual result came in at 116.95%, up 22092.0% from the prior year.
- EBITDA Margin eased to 118.09% in Q1 2026 per BNGO's latest filing, from 107.36% in the prior quarter.
- Over five years, EBITDA Margin peaked at 107.36% in Q4 2025 and troughed at 1214.98% in Q3 2023.
- A 5-year average of 373.59% and a median of 354.92% in 2024 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin plunged 76977 bps in 2023, then soared 60699 bps in 2025.
- Over 5 years, EBITDA Margin stood at 456.81% in 2022, then jumped by 49 bps to 232.75% in 2023, then soared by 37 bps to 146.28% in 2024, then grew by 27 bps to 107.36% in 2025, then fell by 10 bps to 118.09% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 118.09%, 107.36%, and 115.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 7.33% |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | -88.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -88.34% |
| Mar 31, 2026 | -118.09% |
| Dec 31, 2025 | -107.36% |
| Sep 30, 2025 | -115.90% |
| Jun 30, 2025 | -115.85% |
| Mar 31, 2025 | -131.10% |
| Dec 31, 2024 | -146.28% |
| Sep 30, 2024 | -722.89% |
| Jun 30, 2024 | -218.99% |
| Mar 31, 2024 | -354.92% |
| Dec 31, 2023 | -232.75% |
| Sep 30, 2023 | -1,214.98% |
| Jun 30, 2023 | -452.99% |
| Mar 31, 2023 | -510.36% |
| Dec 31, 2022 | -456.81% |
| Sep 30, 2022 | -445.22% |
| Jun 30, 2022 | -480.94% |
| Mar 31, 2022 | -525.68% |
| Dec 31, 2021 | -456.73% |
| Sep 30, 2021 | -444.21% |